From the Journals
Clinical Guidelines

The Most Sensitive Cancer Blood Test Yet

A CRISPR-powered light sensor detected trace amounts of cancer biomarkers in the blood

  • By

  • February 24, 2026

  • 2 min

Share

  • 1

    Ultra-sensitive blood test detects cancer-related microRNAs.

  • 2

    MicroRNAs linked to early tumor development.

  • 3

    Detection limit of 168 zeptomolar significantly surpasses standard methods.

  • 4

    Utilizes second-harmonic generation for enhanced signal detection.

  • 5

    Platform tested with blood samples from lung cancer patients and healthy individuals.

  • 6

    Technology enables monitoring of biomarker levels for personalized treatment.

  • 7

    Promises simple blood screenings before tumors are visible on scans.

Original Source(s)

The Most Sensitive Cancer Blood Test Yet

A CRISPR-powered light sensor detected trace amounts of cancer biomarkers in the blood

  • February 24, 2026

  • 2 min

Related Content

Baptist Health Miami Cancer Institute Names Bruna Pellini, M.D., Chief of Thoracic Medical Oncology

Board-certified thoracic oncologist Bruna Pellini, M.D., has been named chief of thoracic medical oncology at Baptist Health Miami Cancer Institute.

  • by

  • February 6, 2026

  • 3 min
The Role of Human Leukocyte Antigens in Reducing Lung Cancer Risk

With findings that human leukocyte antigen-II (HLA-II) heterozygosity is associated with reduced risk of developing lung cancer, with particular benefits to smokers, Mount Sinai researchers add evidence to the theory of the immune system's protective function against cancer.

  • by

  • February 5, 2025

  • 1 min
Dana-Farber Research News 9.01.2024

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from August 1 through August 15.

  • by

  • September 1, 2024

  • 32 min